Zurich Cantonal Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,718
| Closed | -$175K | – | 2577 |
|
|
2020
Q2 | $175K | Buy |
9,718
+5,023
| +107% | +$69.9K | ﹤0.01% | 1602 |
|
|
2020
Q1 | $33K | Hold |
4,695
| – | – | ﹤0.01% | 2142 |
|
|
2019
Q4 | $112K | Hold |
4,695
| – | – | ﹤0.01% | 1660 |
|
|
2019
Q3 | $126K | Buy |
4,695
+533
| +13% | +$15K | ﹤0.01% | 1491 |
|
|
2019
Q2 | $113K | Hold |
4,162
| – | – | ﹤0.01% | 1548 |
|
|
2019
Q1 | $144K | Buy |
4,162
+64
| +2% | +$1.85K | ﹤0.01% | 1359 |
|
|
2018
Q4 | $80K | Hold |
4,098
| – | – | ﹤0.01% | 1736 |
|
|
2018
Q3 | $109K | Hold |
4,098
| – | – | ﹤0.01% | 1662 |
|
|
2018
Q2 | $155K | Hold |
4,098
| – | – | ﹤0.01% | 1397 |
|
|
2018
Q1 | $134K | Buy |
4,098
+879
| +27% | +$38.6K | ﹤0.01% | 1441 |
|
|
2017
Q4 | $157K | Buy |
3,219
+1,141
| +55% | +$57.7K | ﹤0.01% | 1330 |
|
|
2017
Q3 | $112K | Hold |
2,078
| – | – | ﹤0.01% | 1324 |
|
|
2017
Q2 | $117K | Buy |
2,078
+258
| +14% | +$10.3K | ﹤0.01% | 1272 |
|
|
2017
Q1 | $71K | Hold |
1,820
| – | – | ﹤0.01% | 1572 |
|
|
2016
Q4 | $41K | Hold |
1,820
| – | – | ﹤0.01% | 1834 |
|
|
2016
Q3 | $41K | Buy |
1,820
+246
| +16% | +$5.77K | ﹤0.01% | 1779 |
|
|
2016
Q2 | $37K | Hold |
1,574
| – | – | ﹤0.01% | 1663 |
|
|
2016
Q1 | $32K | Hold |
1,574
| – | – | ﹤0.01% | 1702 |
|
|
2015
Q4 | $81K | Buy |
1,574
+1,096
| +229% | +$53.1K | ﹤0.01% | 1233 |
|
|
2015
Q3 | $20K | Buy |
478
+293
| +158% | +$14.1K | ﹤0.01% | 1503 |
|
|
2015
Q2 | $8K | Hold |
185
| – | – | ﹤0.01% | 1574 |
|
|
2015
Q1 | $7K | Buy |
+185
| New | +$6.36K | ﹤0.01% | 1657 |
|
Zurich Cantonal Bank's PTLA Position: Q3 2020 in Review
Zurich Cantonal Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 9,718 shares — an estimated $175K sold.
Zurich Cantonal Bank first reported a position in PTLA in Q1 2015 and held it in 22 quarters. The position peaked at $175K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Zurich Cantonal Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Zurich Cantonal Bank sold 9,718 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $175K.
- Zurich Cantonal Bank first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 22 quarters.
- Zurich Cantonal Bank's Portola Pharmaceuticals, Inc. position peaked at $175K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Zurich Cantonal Bank's 13F filing for Q3 2020, filed 6 Nov 2020.